These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16905577)

  • 1. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
    Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
    Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
    Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
    Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
    Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
    Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD4
    Zhao L; Li Z; Zeng X; Xia C; Xu L; Xu Q; Song Y; Liu C
    Int J Rheum Dis; 2021 Aug; 24(8):1032-1039. PubMed ID: 34227243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.
    Coulthard LR; Geiler J; Mathews RJ; Church LD; Dickie LJ; Cooper DL; Wong C; Savic S; Bryer D; Buch MH; Emery P; Morgan AW; McDermott MF
    Clin Exp Immunol; 2012 Oct; 170(1):36-46. PubMed ID: 22943199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.
    Monserrat J; Bohórquez C; Gómez Lahoz AM; Movasat A; Pérez A; Ruíz L; Díaz D; Chara L; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
    Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered chemokine receptor profile on circulating leukocytes in human heart failure.
    Athanassopoulos P; Vaessen LM; Balk AH; Weimar W; Sharma HS; Bogers AJ
    Cell Biochem Biophys; 2006; 44(1):83-101. PubMed ID: 16456237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.
    Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; del Barco AA; Sánchez MA; Monserrat J; Prieto A; de la Hera A; Sanz I; Diaz D; Alvarez-Mon M
    J Transl Med; 2015 Jan; 13():2. PubMed ID: 25592233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis.
    Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; Sánchez MA; Monserrat J; de la Hera A; Prieto A; Sanz I; Diaz D; Alvarez-Mon M
    Arthritis Res Ther; 2012 Jul; 14(4):R175. PubMed ID: 22838733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective lymphocyte chemokine receptor expression in the rheumatoid joint.
    Ruth JH; Rottman JB; Katschke KJ; Qin S; Wu L; LaRosa G; Ponath P; Pope RM; Koch AE
    Arthritis Rheum; 2001 Dec; 44(12):2750-60. PubMed ID: 11762935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.